Skip to content

Saige-Dx

by DeepHealth, Inc. 3 variants

510(k) K220105

Saige-Dx is a medical device (FDA Class II; FDA product code QDQ) made by DeepHealth, Inc., cleared under FDA 510(k) K220105 on 12 May 2022, active as of 10 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 10 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 10 Oct 2026.

Regulatory status

as of registry sync 10 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK220105 Date12 May 2022ClearedStatusActive

Official records

From the FDA record

Received by the FDA
12 Jan 2022
FDA decision
12 May 2022 (Substantially Equivalent)
FDA review time
120 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K220105 (openFDA), as read on 10 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
QDQ
Device class
Class II
Regulation
21 CFR Part 892.2090
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code QDQ (Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer).

Other devices from Deephealth

See all devices from Deephealth →